144 related articles for article (PubMed ID: 32802093)
1. CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide.
Zabihi M; Safaroghli-Azar A; Gharehbaghian A; Allahbakhshian Farsani M; Bashash D
Iran J Pharm Res; 2019; 18(Suppl1):119-131. PubMed ID: 32802093
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.
Pourbagheri-Sigaroodi A; Safaroghli-Azar A; Shanaki M; Yousefi AM; Anjam Najmedini A; Bashash D
Iran J Pharm Res; 2020; 19(3):144-155. PubMed ID: 33680018
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Effects of PI3K Inhibition on Arsenic Trioxide Cytotoxicity in Acute Promyelocytic Leukemia Cells: A New Portrait of Idelalisib as an Adjuvant Therapy.
Dadashi M; Pourbagheri-Sigaroodi A; Anjam-Najmedini A; Bashash D
Indian J Hematol Blood Transfus; 2023 Apr; 39(2):208-219. PubMed ID: 37006983
[TBL] [Abstract][Full Text] [Related]
4. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells.
Liu XJ; Wang LN; Zhang ZH; Liang C; Li Y; Luo JS; Peng CJ; Zhang XL; Ke ZY; Huang LB; Tang YL; Luo XQ
J Cancer; 2020; 11(12):3476-3482. PubMed ID: 32284743
[TBL] [Abstract][Full Text] [Related]
6. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
[TBL] [Abstract][Full Text] [Related]
7. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
[TBL] [Abstract][Full Text] [Related]
8. Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines.
Mohammadi Kian M; Haghi A; Salami M; Chahardouli B; Rostami SH; Malekzadeh K; Kamranzadeh Foumani H; Mohammadi S; Nikbakht M
Cell J; 2020 Jul; 22(2):193-202. PubMed ID: 31721534
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
Bashash D; Sayyadi M; Safaroghli-Azar A; Sheikh-Zeineddini N; Riyahi N; Momeny M
Int J Biochem Cell Biol; 2019 Mar; 108():7-16. PubMed ID: 30639430
[TBL] [Abstract][Full Text] [Related]
10. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
[TBL] [Abstract][Full Text] [Related]
11. Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?
Haghi A; Salami M; Mohammadi Kian M; Nikbakht M; Mohammadi S; Chahardouli B; Rostami SH; Malekzadeh K
Cell J; 2020 Oct; 22(3):253-262. PubMed ID: 31863650
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
Li X; Ding X; Adrian TE
Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
[TBL] [Abstract][Full Text] [Related]
13. Quercetin simultaneously induces G
Chang JL; Chow JM; Chang JH; Wen YC; Lin YW; Yang SF; Lee WJ; Chien MH
Environ Toxicol; 2017 Jul; 32(7):1857-1868. PubMed ID: 28251795
[TBL] [Abstract][Full Text] [Related]
14. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
15. NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status.
Sayyadi M; Safaroghli-Azar A; Safa M; Abolghasemi H; Momeny M; Bashash D
Iran J Pharm Res; 2020; 19(1):153-165. PubMed ID: 32922477
[TBL] [Abstract][Full Text] [Related]
16. Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells.
Chen P; Zhan W; Wang B; You P; Jin Q; Hou D; Wang X; You R; Zou H; Chen Y; Huang H
Exp Cell Res; 2019 Mar; 376(2):114-123. PubMed ID: 30763586
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
Bonati A; Rizzoli V; Lunghi P
Curr Pharm Biotechnol; 2006 Dec; 7(6):397-405. PubMed ID: 17168655
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
Bashash D; Delshad M; Riyahi N; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M
Eur J Pharmacol; 2018 Dec; 841():10-18. PubMed ID: 30316766
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2019 Jun; 513(3):589-593. PubMed ID: 30979499
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
